What’s going on here?
On November 15, 2024, the FTSE 100 edged up by 0.1%, driven by a recovery in mining stocks, while the FTSE 250 remained unchanged amid slumping pharmaceutical stocks.
What does this mean?
The FTSE 100’s slight uptick reflects a tug-of-war between sector gains and losses. Mining stocks rebounded, offsetting earlier hits to the index caused by AstraZeneca and GSK’s share declines of 2.4% and 3.2%, respectively. Pharma’s drop stemmed from vaccine market jitters after the controversial appointment of Robert F. Kennedy Jr. as head of the US Department of Health and Human Services. Economically, the UK’s GDP shrank by 0.1% in September, bucking growth forecasts and highlighting fiscal challenges. However, forthcoming financial regulation reforms could ease growth barriers, hinting at potential long-term economic shifts.
Why should I care?
For markets: Mining stocks dig deep, pharma faces scrutiny.
Mining stocks’ rebound…
